Complications Substantially Reduced in Latest Prostate Cryosurgery Multi-Center Study.Business Editors and Health/Medical Writers BIOWIRE2K UNIONDALE, N.Y.--(BW HealthWire)--May 30, 2002 Galil Medical's SeedNet(TM) Gold third generation system proven simple, safe and effective A late breaking abstract presented at the annual American Urological Society meeting in Orlando, Florida this week indicated that 17 gauge ultra-thin CryoNeedles(TM), manufactured by Galil Medical, are effective, easy to use and demonstrate fewer complications in patients with localized prostate cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. . The abstract summarized the latest data from a prospective multi-center study. The ongoing study (at prestigious medical centers including UCLA UCLA University of California at Los Angeles UCLA University Center for Learning Assistance (Illinois State University) UCLA University of Carrollton, TX and Lower Addison, TX School of Medicine, Mayo Clinic, Rochester, MN and Allegheny General Hospital Allegheny General Hospital is a large urban hospital located in Pittsburgh, Pennsylvania, USA. Allegheny General Hospital, also commonly known locally by the acronym "AGH," was founded in 1885 in Pittsburgh's North Side, in the area formally known as Allegheny City. , Pittsburgh, PA) includes 122 patients to date, with no reported cases of urethral-rectal fistulas or urethral strictures. Complications such as urinary incontinence Urinary Incontinence Definition Urinary incontinence is unintentional loss of urine that is sufficient enough in frequency and amount to cause physical and/or emotional distress in the person experiencing it. were substantially lower overall compared to complications in patients treated with larger cryo probes. James McGlone, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. stated, "This study is confirmation that our patented 17-gauge ultra-thin CryoNeedles provide a proven benefit to patients that are seeking a minimally invasive, radiation-free treatment for their prostate cancer. It is quickly becoming widespread due to its clinical effectiveness and low side effects. We have noticed very high interest levels from physicians here at the AUA AUA American Urological Association, see there meeting because they are interested in providing this revolutionary treatment option to their patients." Galil Medical Ltd. Galil Medical Ltd., with operations in Israel and the U.S., specializes in the development, manufacture, and marketing of state-of-the-art minimally invasive medical products and systems. The company's new generation of innovative, high-resolution SeedNet(TM) Gold cryo-therapy for the treatment of prostate cancer, features patented ultra-thin CryoNeedles(TM) that are inserted through a template in a method similar to brachytherapy. SeedNet(TM) Gold applies temperatures as low as minus 180 degrees Celsius for complete destruction of tissue. Incorporating advanced hypercooling technology, the Galil system allows extremely fast, high-resolution, and controlled destruction of cancerous tissue. Lumenis, Ltd., formerly ESC See escape character and escape key. See also ESC/P. ESC - escape Medical Systems, Ltd. (Nasdaq: LUME LUME Light Utilization More Efficient ) and Elron Electronics Industries Ltd. (Nasdaq: ELRN) are major shareholders of Galil Medical. Visit the Galil Medical Website at www.galilmedical.com for more information. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion